A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Salloway S, Farlow M, McDade E, Clifford DB, et al. Nat Med 2021 Jun 21. pii: 10.1038/s41591-021-01369.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Salloway S, Farlow M, McDade E, Clifford DB, et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nat Med 2021 Jun 21. pii: 10.1038/s41591-021-01369.
PMID: 34155411